Vanda Pharmaceuticals
VNDA
#8815
Rank
C$0.32 B
Marketcap
C$5.30
Share price
-6.42%
Change (1 day)
-12.32%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -C$0.26 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are C$0.21 Billion. In 2025 the company made an earning of -C$0.22 Billion a decrease over its 2024 earnings that were of -C$56.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.26 Billion22.75%
2025 -C$0.22 Billion271.79%
2024 -C$56.82 Million191.43%
2023 -C$19.5 Million-320.45%
2022 C$8.84 M-84.99%
2021 C$58.91 M54.8%
2020 C$38.06 M19.42%
2019 C$31.87 M4.93%
2018 C$30.37 M-228.6%
2017 -C$23.62 Million-8.98%
2016 -C$25.95 Million-53.79%
2015 -C$56.16 Million-30.18%
2014 -C$80.43 Million173.08%
2013 -C$29.45 Million-25.33%
2012 -C$39.44 Million163.61%
2011 -C$14.97 Million-221.15%
2010 C$12.34 M-124.53%
2009 -C$50.35 Million-29.44%
2008 -C$71.36 Million-36.2%
2007 -C$0.12 Billion21.81%
2006 -C$91.82 Million170.55%
2005 -C$33.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.62 B-14,215.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.68 B-8,459.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.65 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$46.94 B-18,194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.74 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.64 B-6,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-C$3.92 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA